This webinar will outline a holistic approach to ensure continued compliance, taking into account the expected changes, including the need for EM. The recent 2020 draft of EU GMP Annex 1, which regulates the manufacture, control and release of sterile pharmaceutical products in the EU, signals that there are comprehensive changes to come.
